Trials / Not Yet Recruiting
Not Yet RecruitingNCT07233746
Comparison of QIPB and SIFICB in Hip Surgery
Comparison of the Effects of Quadroiliac Plane Block Versus Suprainguinal Fascia Iliaca Compartment Block on Postoperative Pain in Hip Surgery
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cumhuriyet University · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to compare the postoperative analgesic effects of Quadroiliac Plane Block (QIPB) and Suprainguinal Fascia Iliaca Compartment Block (SIFICB) in patients undergoing hip surgery.
Detailed description
Patients were divided into two randomized groups: Group 1 (QIPB group, n=30) and Group 2 (SIFICB group, n=30). All patients will receive the same standard general anesthesia per hospital protocol. All blocks will be applied with the same ultrasonography and block equipment, and by the same physician. After the anesthesia induction, patients in Group 1 will receive Quadroiliac Plane Block (QIPB) with 40 mL of 0.25% bupivacaine. Patients in Group 2 will receive Suprainguinal Fascia Iliaca Compartment Block (SIFICB) with 30 mL of 0.25% bupivacaine. All patients will receive Paracetamol 1gr and Dexketoprofen 50mg intravenous (IV) 10 minutes prior to skin closure. Routine analgesic procedure consisting of 3x400mg Ibuprofen will be followed postoperatively for 24 hours. Numeric Rating Scale (NRS) will be used to assess postoperative pain on 1st, 6th, 12th, 18th and 24th hours after the surgery. Tramadol 1mg/kg IV will be administered as a rescue analgesic for all patients if NRS score is higher than 4. Total Tramadol consumption will be calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Quadro-İliac Plane Block(QİPB) | 40 mL of 0.25% bupivacaine |
| PROCEDURE | Suprainguinal Fascia Iliaca Compartiment Block | 30 mL of 0.25% bupivacaine |
Timeline
- Start date
- 2025-12-15
- Primary completion
- 2026-04-01
- Completion
- 2026-05-01
- First posted
- 2025-11-18
- Last updated
- 2025-11-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07233746. Inclusion in this directory is not an endorsement.